Humatrope® (somatropin [rDNA origin]) – PRODUCT INFORMATION

Humatrope® [somatropin (rDNA origin) injection]
HUMATROPE is available in powder formulation or cartridges.
The powder form is supplied with vials and must be mixed (reconstituted) with sterile water prior to an injection and administered with a syringe. The prefilled formulation is administered with the HumatroPen® device.
Approved for the following diagnoses:

• Growth hormone deficiency (GHD) in children and adults
• Turner Syndrome
• Idiopathic Short Stature

For more information, please visit Humatrope.com or download the full prescribing information.

Humatrope is a registered trademark of Eli Lilly and Company.